| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 37.25B | 44.49B | 35.46B | 31.85B | 26.55B | 21.10B |
| Gross Profit | 18.03B | 16.31B | 19.38B | 17.52B | 13.79B | 11.17B |
| EBITDA | 9.29B | 10.81B | 9.26B | 8.63B | 6.40B | 5.05B |
| Net Income | 6.13B | 6.40B | 6.01B | 5.17B | 3.95B | 3.62B |
Balance Sheet | ||||||
| Total Assets | 68.73B | 74.64B | 65.37B | 38.65B | 30.60B | 25.96B |
| Cash, Cash Equivalents and Short-Term Investments | 5.77B | 8.48B | 26.28B | 3.06B | 2.98B | 838.21M |
| Total Debt | 2.11B | 4.42B | 2.02B | 4.12B | 2.95B | 1.51B |
| Total Liabilities | 10.08B | 13.32B | 8.92B | 10.65B | 7.70B | 5.95B |
| Stockholders Equity | 57.13B | 59.83B | 54.95B | 26.50B | 22.90B | 20.00B |
Cash Flow | ||||||
| Free Cash Flow | 321.63M | 2.83B | 3.58B | 3.73B | 1.98B | 973.68M |
| Operating Cash Flow | 3.40B | 7.75B | 7.75B | 6.93B | 5.33B | 4.45B |
| Investing Cash Flow | -11.58B | -16.89B | -17.65B | -4.72B | -5.63B | -3.53B |
| Financing Cash Flow | -1.16B | 7.68M | 19.44B | -1.75B | 187.45M | -636.60M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | ₹353.12B | 38.96 | ― | 0.65% | 25.80% | 3.90% | |
71 Outperform | ₹189.27B | 39.99 | ― | 0.75% | 8.74% | -2.07% | |
66 Neutral | ₹169.18B | 39.31 | ― | 0.47% | 13.23% | 24.72% | |
62 Neutral | ₹523.26B | 50.99 | ― | 0.48% | 2.87% | 13.55% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
59 Neutral | ₹155.11B | 63.58 | ― | ― | 22.31% | 14.98% | |
50 Neutral | ₹102.14B | 37.75 | ― | 0.38% | 3.88% | -85.35% |